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We have investigated the apoptotic levels and expression of the apoptotic inducer Bak in non-melanoma skin cancers.
Squamous cell carcinomas of known human papillomavirus status from immunocompetent patients were analysed for the
expression of the Bak protein, and the expression proﬁle was compared both to the presence of apoptotic cells and the
proliferation marker Ki-67. We demonstrate an inverse correlation between human papillomavirus positivity and Bak
expression in squamous cell carcinomas, with concomitantly fewer apoptoic cells being detected in the human papillomavirus
positive tumours. Bak expression was not observed in basal cell carcinomas irrespective of human papillomavirus status,
suggesting that Bak only plays a role in signalling apoptosis in squamous, but not basal, cell cancers. No differences were
observed in the proliferation rates between papillomavirus positive and negative squamous cell tumours. However, a
signiﬁcant decrease in the number of apoptotic cells was observed in human papillomavirus-positive squamous cell carcinomas
which suggests that the virus may have signiﬁcantly altered the relationship between proliferation and apoptosis in a
proportion of these tumours.
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Non-melanoma skin cancer (NMSC) is the commonest malignancy
in Caucasian populations with around 40000 new cases arising
each year in the UK and about 1 million in the USA. The cumu-
lative effect of solar ultra-violet B (UVB) radiation at 280–320 nm
wavelengths is a key environmental risk factor in the aetiology of
the disease (de Gruijl and Van der Leun, 1994; Kraemer, 1997;
Miralles et al, 1998). In addition to UVB, other factors such as
immunological status, genetic predisposition and infection by
human papillomavirus (HPV) may also contribute towards NMSC
development (Proby et al, 1996). These cancers typically arise at
body sites exposed to UVB and recent epidemiological studies have
revealed that about 30% of squamous cell carcinomas (SCC) in
immunocompetent individuals harbour HPV DNA (Harwood et
al, 2000, and references therein). In iatrogenically immunosup-
pressed organ transplant recipients the carriage of HPV DNA in
SCCs rises dramatically to about 80% with a wide spectrum of
HPV types being present (Harwood et al, 2000). Whether the virus
plays an active role in the development of lesions carrying HPV
DNA is currently the focus of many investigations.
Acute UVB exposure leads to the formation of ‘sunburn’ cells
within the epidermis which display characteristics, such as
condensed nuclei, that is typical of apoptotic cells (Young, 1987;
Schwarz et al, 1995). The apoptotic response of cells within the
epidermis is in part dependent on the p53 tumour suppressor
protein (Brash et al, 1996; Ziegler et al, 1996), however other
p53-independent mechanisms have also been identiﬁed (Gniadecki
et al, 1997). Whilst the role of p53 in protecting the epidermis
from UV-induced skin carcinomas is clearly established in murine
models (Donehower et al, 1992; Ananthaswamy et al, 1997; Jiang et
al, 1999), there is conﬂicting evidence as to the protective role of
p53 in adult human skin. In particular, the suggested lack of
pre-cancerous potential of the many clonal patches of p53 mutant
cell clones within the epidermis (Jonason et al, 1996; Ren et al,
1996a,b), together with the lack of increase in NMSC frequency
in Li-Fraumeni patients (Malkin et al, 1990), suggests that both
p53-dependent and independent surveillance mechanisms may be
critical in eliminating UVB damaged cells. P53 immunostaining,
which is often indicative of a dysfunction in the p53 pathway, is
observed in about 40% of SCCs (McGregor et al, 1997). However,
this aberrant p53 expression does not correlate with the number of
apoptotic cells observed in SCCs (Wikonkal et al, 1997; Jackson et
al, 2000). The persistence of cells which have acquired somatic
mutations as a direct result of UV-induced photoproduct forma-
tion (Herzinger et al, 1995) may lead to the propagation of
deleterious mutations and ultimately to carcinogenesis. In addition
to the epidemiological studies on the presence of HPV DNA in
these tumours, we have been studying the molecular activities of
the viral proteins to determine whether they possess functions that
are consistent with a role in tumour formation. We have recently
demonstrated that the E6 protein from a diverse spectrum of HPV
types is able to efﬁciently inhibit apoptosis in cell culture systems
in response to UVB damage (Jackson and Storey, 2000). In addi-
tion, we have shown that the Bak protein, an apoptogenic
member of the Bcl-2 family, is induced to high levels in the epider-
mis in response to UVB that in turn leads to apoptosis. The E6
protein of cutaneous HPVs efﬁciently targets Bak for proteolytic
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models of regenerated epithelium (Jackson et al, 2000). This
suppression of apoptosis suggests a mechanism by which the virus
may play a general role in promoting SCC development. To inves-
tigate this further, we have analysed a series of both HPV positive
and negative SCCs and basal cell carcinomas (BCCs) for Bak
expression and correlated this with the proliferative potential of
the tumour and apoptotic levels.
MATERIALS AND METHODS
Patients and tumours
Lesions comprised of 24 CIS/SCCs from 20 patients and 16 BCC
lesions derived from 16 patients. All patients were immunocompe-
tent and tumour diagnosis was conﬁrmed histologically. All lesions
were 1–1.5 cm in size. Each sample was bisected and half frozen at
7708C at the time of surgery. Ethical approval for this study was
obtained from the East London and City Health Authority
Research Ethics Committee.
HPV typing of lesions
DNA from frozen tumour tissue were subjected to HPV typing
using a degenerate PCR strategy that we have previously demon-
strated to detect all known HPV types (Harwood et al, 2000).
Western blotting
Proteins were extracted from 5 mm section by resuspending the
tissue in 100 ml2 6SDS sample buffer, vortexing and then heating
to 1008C for 5 min. Ten ml of each sample was then electrophor-
esed on 12% SDS polyacrylamide gels and either stained with
coomassie blue or transferred to PVDF membrane for Western blot
analysis. Primary antibodies were diluted according to manufac-
turers instructions. The secondary antibody was a HRP-coupled
rabbit anti-mouse serum used at 1:1000 dilution (Dako) and
detection of proteins was by ECL-Plus (Amersham Pharmacia
Biotech).
Antibodies and immunohistochemistry
Antibodies for Western blotting were: Bak (Ab-2, Calbiochem),
W6/32 (MHC class 1, Serotech), actin (Dako).
HPV positive and HPV-negative SCCs tumours and BCCs were
investigated using standard immunohistochemical techniques for
protein expression of Bak, Ki-67 and by apoptosis as judged by
TUNEL staining. Four mm thick formalin ﬁxed parafﬁn embedded
tissue sections were deparafﬁnized and rehydrated through graded
alcohols to water. A minimum of two sections were examined for
each parameter. Endogenous peroxidase activity was blocked by
incubation with 0.03% H2O2 for 10 min. The sections which were
used to detect Ki-67 (Dako Ltd, 1:800 dilution) expression were
returned to water and then immersed in preheated 10 mM citrate
buffer, pH 6.0 and microwaved for 8 min, then blocked with horse
serum and incubated in the primary antibody overnight at 48C. For
detection of Bak protein expression (Ab-2, Calbiochem, 1:100 dilu-
tion), the slides were immersed in 10 mM citrate buffer and then
boiled in a microwave for a total of 15 min consisting of three
5 min periods. The slides were then left to cool for 20 min before
taking them back to water and then blocking with horse serum.
The primary antibody was then applied for 4 h at room tempera-
ture. For both antibodies the rest of the procedure was the same.
Brieﬂy, the sections were rinsed with Tris buffer saline (TBS) and
the biotinylated antibody from the universal streptavidin-biotin
kit (Vector Lab) applied for 30 min, before rinsing with TBS. The
third layer peroxidase labelled streptavidin was applied for another
30 min and the sections rinsed again before developing using
diaminbenzidine (DAB). The sections were then lightly counter-
stained using Gill’s haematoxylin, dehydrated in graded alcohols,
cleared in xylene and mounted using DePex (Metk Ltd). TUNEL
staining of tissue was carried out according to manufacturers
instructions (Promega, DeadEnd colorimetric apoptosis detection
system), using a 5 mgm l
71 Proteinase K incubation for 5 min.
Each tissue section was then scored by two independent asses-
sors without knowledge of the clinical details or HPV status of
the lesion.
The entire tumour section was assessed and analysis was carried
out on a quantitative basis with the following grading applying
throughout: 7:no staining; positive staining was scored follows:
+:5/= 5% of tumour cells positive; ++:45–25%; +++:25–
50%; ++++:450–75%; +++++:475–100%. Statistical analysis
was performed using Fishers exact test.
RESULTS
HPV positive and negative tumours were investigated using stan-
dard immunohistochemical techniques for expression of the Bak
protein, the proliferation marker Ki-67 and apoptosis as judged
by TUNEL staining. Three out of 10 of the HPV positive biopsies
were carcinoma in situ (CIS) and the remaining seven were SCCs;
the HPV-negative tumours comprised two CIS and 12 SCC samples.
Of the HPV-positive samples, ﬁve displayed Bak staining and this
was restricted to the lowest scoring index with only a few cells being
scored positive in the entire tumour section, whilst more of the
HPV negative SCCs showed staining which was often of a higher
scoring index, but did not reach statistical signiﬁcance in our study
(P=0.440). The Bak staining was cytoplasmic in all cases which is
consistent with its subcellular mitochondrial localisation. Concomi-
tant with Bak expression, only one sample showed evidence of
apoptosis, but staining with Ki-67, a large protein present in the
nuclei of all proliferating cells, revealed however that the tumours
were highly proliferative (Table 1). In marked contrast, 11 out of
14 of the HPV-negative tumours displayed Bak staining, with three
samples having strong staining throughout the tumour (Table 1). A
most notable ﬁnding was that there was an increase in TUNEL posi-
tivity that accompanied the increased Bak staining in the HPV-
negative SCCs compared to the HPV-positive samples (P=0.008),
whilst no differences were observed in Ki-67 staining index relative
to the HPV status. Bak staining was restricted to the tumour mate-
rial and was never detected in the overlying epidermis or stroma.
Representative examples of different grades of Bak, Ki-67 and
TUNEL staining are shown in Figure 1A. In order to verify that
the increased Bak immunohistochemical staining was reﬂective of
high Bak protein levels in the tumour, two 5 mm sections of similar
sized tumour were cut from Bak positive and negative lesions,
patients 17 and 4 respectively. The extracted proteins were electro-
phoresed on SDS–PAGE gels and the proteins transferred to
PVDF membranes for Western blot analysis. Coomassie blue stain-
ing of the samples indicated that they contained equal amounts of
protein, but in addition to Bak the membranes were also re-probed
for actin and MHC class 1. Western blotting conﬁrmed that Bak
was easily detected in the section that showed positive immunohis-
tochemical Bak staining (from lesion 17), but not in the Bak
negative tumour sections (from lesion 4) (Figure 1B). Whilst both
tumours showed MCH class 1 staining, we note that the Bak nega-
tive lesion expressed actin whilst in the Bak positive lesion actin
expression was much lower, suggesting a degree of heterogeneity
between the tumour samples. There was no clear correlation
between Bak expression and TUNEL positivity (Table 1). This
may be due to the expression of apoptotic inducers such as Bak
being a prerequisite to apoptotic cell formation and also that host
cell protein synthesis is frequently shut down as cells as they under-
go apoptosis.
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to those of the SCC samples. Bak was not detected in any of the
seven HPV-positive BCCs compared to ﬁve out of 10 SCCs
(P=0.003), or nine HPV-negative BCC samples, in comparison to
11 out of 14 HPV positive samples (P=0.0005). All the HPV-posi-
tive and negative BCCs showed evidence of proliferation, but no
marked differences in Ki-67 staining were observed between the
two groups. In addition, only one out of seven HPV positive
BCC samples were TUNEL positive. A signiﬁcant difference was
observed however between the TUNEL staining of the HPV nega-
tive BCCs and SCCs, where only two out of nine BCCs were
TUNEL positive compared to 10 out of 14 of the SCCs
(P=0.0266) (Table 2).
DISCUSSION
Our recent ﬁndings that a diverse spectrum of HPV types were able
to inhibit apoptosis (Jackson and Storey, 2000), coupled with the
fact that UVB is a potent inducer of the Bak protein and that
the HPV E6 protein abrogates Bak function (Jackson et al,
2000), suggested that the virus may be altering the balance between
apoptosis and proliferation in HPV-containing lesions. To test this
hypothesis, we have investigated a series of HPV positive and nega-
tive SCCs for apoptosis and proliferation. We demonstrate that the
HPV positive lesions displayed little or no Bak staining and had
few apoptotic cells whilst still maintaining a high proliferative
potential. In distinct contrast, the HPV negative tumours were
more heterogeneous and frequently showed higher levels of Bak
expression and apoptosis. We conclude from these studies that
HPVs may signiﬁcantly alter the proﬁle of apoptotic inducers such
as Bak and that the rate of apoptosis has been altered in the HPV-
positive tumours. Such a perturbation may have signiﬁcant clinical
implications for the development of such lesions since both HPV
positive and negative SCCs were highly proliferative as assessed
by Ki-67 immunoreactivity (Arends et al, 1994). Whether such
an effect inﬂuences the accumulation of deleterious mutations
induced by UVB (Grifﬁths et al, 1998) or alters the pattern of
chromosome loss (Quinn et al, 1994) in these tumours remains
to be determined. We have also noted that HPV positive and nega-
tive tumours can occur in the same individuals, such as patients 5
and 10 in Table 1. Whilst this may indicate that the HPV may be a
passenger in such lesions, an alternative explanation and one that is
common to other virally associated tumours, is that the tumour
may develop in the absence of viral infection through an alternative
mechanism that involves the accumulation of mutations in critical
cellular genes.
Although HPV DNA copy number in such lesions is high
enough to be detected by Southern blotting (see Proby et al,
1996 for an overview), we have employed a degenerate PCR-based
approach that is capable of detecting all known HPV types that
does not require large amounts of DNA and a prior knowledge
of the HPV DNA status. This methodology is not as sensitive as
PCR using type-speciﬁc primers and does not enable us to estimate
accurately the copy number of the virus in the lesions and whether
all cells contain virus and express viral proteins. Future experi-
ments aimed at determining the level and pattern of E6 gene
expression in these lesions will be most informative.
Whether a higher viral load coupled with increased E6 expres-
sion would further alter Bak expression or apoptotic rates
remains to be determined. We also noted that the HPV samples
that were positive for Bak expression by immunohistochemistry
displayed only a few cells that scored positive. Whether this reﬂects
a heterogeneous expression of the HPV genes within the tumour
remains to be investigated in greater detail.
As none of the BCC tumours in our study expressed Bak our
ﬁndings also suggest that this mechanism of apoptosis in NMSC
is restricted to SCCs. The frequent over-expression of anti-apopto-
tic proteins such as Bcl-2 in BCCs (Cerroni and Kerl, 1994;
Verhaegh et al, 1995; Crowson et al, 1996; Wikonkal et al, 1997;
Chang et al, 1998; Miralles et al, 1998) may account for the lack
of observed apoptosis. In summary, our ﬁndings reveal an inverse
correlation between the presence of HPV DNA and apoptosis in
SCCs which suggests that inhibition of apoptosis by HPVs may
contribute towards the development of a proportion of these
lesions.
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Table 1 Expression of proliferation and apoptotic markers in HPV
positive and negative lesions
Patient No. Lesion Site HPVs Bak Ki-67 TUNEL
HPV positive lesions
1 CIS Chin 25 7 ++ 7
2 SCC Ear pso x1 + +++ +
3 SCC Leg 1A16 + ++ 7
4 SCC Inner Canthus 15-rel 7 + 7
5 SCC Hand pso x1 7 +++ 7
6 SCC Cheek 21 + +++ 7
7 CIS Forearm 16 7 ++++ 7
8 SCC Forearm Z95970 7 +++ 7
9 CIS Buttock 5 + ++ 7
10 SCC Ear X9-r + ++++ 7
HPV Negative lesions
5 SCC Scalp – +++ +++ +
10 SCC Hand – ++ +++ 7
11 SCC Leg – + ++ +
12 SCC Leg – ++ + +
13 SCC Forearm – ++++ ++ +
13 CIS Buttock – 7 ++ 7
13 CIS Calf – 7 ++ 7
14 SCC Leg – + + +++
15 SCC+BCC Ear – + + +
16 SCC Ear – + ++ +
17 SCC Forearm – +++ +++ ++
18 SCC Ear – + + +
19 SCC Calf – + +++ ++
20 SCC Temple – ++ ++ 7
CIS=carcinoma in situ; SCC=squamous cell carcinoma; TUNEL=terminal transferase
dUTP nick end labelling.
Table 2 Expression of prolilferation and apoptotic markers in HPV
positive and negative basal cell carcinomas (BCC)
Patient No. Lesion Site HPVs Bak Ki-67 TUNEL
HPV positive lesions
21 BCC Neck AF019978 7 ++ 7
22 BCC – 9 7 + 7
23 BCC Forehead RTRx9 7 +++ +
24 BCC Back 9 7 ++ 7
25 BCC Ear pso x1 7 + 7
26 BCC – pso x1, 6 7 ++ 7
27 BCC Neck X7, pso x1 7 ++ 7
HPV negative lesions
28 BCC Back – 7 ++
29 BCC Scalp – 7 +++ 7
30 BCC Cheek – 7 ++ 7
31 BCC Forearm – 7 ++ 7
32 BCC Scalp – 7 ++
33 BCC Scalp – 7 + 7
34 BCC Ear – 7 ++ 7
35 BCC – – 7 + 7
36 BCC Scalp – 7 + 7
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Figure 1 (A) Immunohistochemical detection of Bak, Ki-67 and TUNEL in SCCs. Shown are serial tumour sections that were analysed for the expression
of the pro-apoptotic protein Bak, the proliferation marker Ki-67 and the proportion of cells undergoing apoptosis, as judged by TUNEL. The scoring system
employed is as described in the text. Original magniﬁcation 1006.( B) Western blot analysis of Bak positive and negative SCCs. Proteins extracted from
equal amounts of tumour material were subjected to SDS–PAGE and Western blotting for Bak, actin and MHC class 1 (W6/32) expression. Tumours 4 and
17 were selected as being representative of Bak negative and positive immunohistochemical staining.
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